Loading...
Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS
OBJECTIVE: To investigate the effect of different natalizumab washout (WO) periods on recurrence of MRI and clinical disease activity in patients switching from natalizumab to fingolimod. METHODS: In this multicenter, double-blind, placebo-controlled trial (TOFINGO), patients with relapsing-remittin...
Na minha lista:
| Udgivet i: | Neurology |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Lippincott Williams & Wilkins
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4501941/ https://ncbi.nlm.nih.gov/pubmed/26024899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000001706 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|